PAVmed Inc. (PAVM) Tops Q3 EPS by 5c

PAVmed Inc. (NASDAQ: PAVM) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $790 thousand versus the consensus estimate of $658 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance